Comparison of efficacy of a new painkiller medicine namely Lornoxicam (extended release) and commonly used medicine Diclofenac for pain control following impacted wisdom teeth removal
- Conditions
- Health Condition 1: K011- Impacted teeth
- Registration Number
- CTRI/2024/02/062947
- Lead Sponsor
- Terna Dental College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients who are willing to participate in the study
2.Patients requiring surgical extraction of bilateral impacted mandibular 3rd molar of similar difficulty (easy or moderate difficulty as per Pederson’s difficulty index)
3.Healthy patients belonging to ASA Class I or II will be included
4.Patients who are not on any pain management therapy or those who have not consumed any NSAID in the last seven days.
1.Patients not willing to participate in the study
2.H/o Hypersensitivity reactions to Lornoxicam, Diclofenac or any other NSAID
3.Pregnant and lactating patients
4.Patients suffering from Bronchial Asthma or COPD or bleeding diathesis.
5.Patients with H/o gastritis, gastric/ duodenal ulcers, or any other inflammatory gastrointestinal disease
6.Pederson difficulty index score 7-10 (Difficult)
7.Patients having local signs of infection around the impacted tooth to be removed such as periapical abscess/granuloma, pericoronal abscess, fascial space infection etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain evaluation using modified visual analogue scale (0-10)Timepoint: 4 hour, 8 hour, 12 hour, 24 hour, 48 hour, 72 hour
- Secondary Outcome Measures
Name Time Method Swelling evaluation described by Gabka and Matsumara scaleTimepoint: Postoperative Day 1 and Postoperative Day 3